Cutting Costs, Not Care: New Models for Affordable Men's Health Medications

    November 2025 in “ Urology ”
    Stephen Tranchina, H Moreland, Madeline Snipes … Nicholas A. Deebel
    Studysummary This study found that the Mark Cuban Cost Plus Drug Company offers significant cost savings on men's health medications compared to both Medicare and GoodRx, particularly for erectile dysfunction treatments.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on goldjournal.net →
    Discuss this study in the Community →

    Research cited in this study 1

    1. Urological Drug Price Stewardship: Potential Cost Savings Based on the Mark Cuban Cost Plus Drug Company Model The Journal of Urology · 2022